Funding
← Back to your selection

Scottish National Investment Bank

Activity from announced rounds

Activity in this selectionOct 18, 2026 · Jul 21, 2026
Rounds participated in
2
Confirmed lead rounds
1
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$76.6M
2 disclosed · full round size, not this investor’s share

By stage

Series B2

By primary sector

Biotech1
Industrial tech1

By country

United Kingdom2

Rounds

2 in this selection
iGii

iGii makes Gii, a three-dimensional porous carbon nanomaterial, and develops industrial sensing, heating and battery-electrode applications from it.

€26.5MSeries B
Lead
Mironid

Mironid develops small-molecule medicines for inherited kidney disease, with a lead programme targeting autosomal dominant polycystic kidney disease.

$46MSeries B
Participant